A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virus-Reference-Cited by-同舟云学术

A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virus

Published:2021-05-17 Issue:3 Volume:2 Page:430-441
ISSN:2688-2663
Container-title:MedComm
language:en
Short-container-title:MedComm

Author:

He Cai¹^ORCID,Yang Jingyun¹,He Xuemei¹,Hong Weiqi¹,Lei Hong¹,Chen Zimin¹,Shen Guobo¹²,Yang Li¹²,Li Jiong¹²,Wang Zhenling¹²,Song Xiangrong¹,Wang Wei¹²,Lu Guangwen¹²,Wei Xiawei¹²^ORCID

Affiliation:

1. Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics West China Hospital, Sichuan University Chengdu China

2. WestVac Biopharma Co. Ltd. Chengdu China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mco2.72

Reference28 articles.

1. Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID‐19;Ni Y;Mol Biomed,2021

2. The variant gambit: COVID-19’s next move

3. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy

4. A pneumonia outbreak associated with a new coronavirus of probable bat origin

5. Rapid COVID-19 vaccine development

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and protective efficacy of the HC009 mRNA vaccine against SARS-CoV-2;Frontiers in Immunology;2024-07-26

2. A chimeric adenovirus‐vectored vaccine based on Beta spike and Delta RBD confers a broad‐spectrum neutralization against Omicron‐included SARS‐CoV‐2 variants;MedComm;2024-04-27

3. A superior heterologous prime‐boost vaccination strategy against COVID‐19: A bivalent vaccine based on yeast‐derived RBD proteins followed by a heterologous vaccine;Journal of Medical Virology;2024-03

4. Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model;Vaccine;2024-02

5. Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters;Communications Medicine;2023-05-26